Market Overview:
The global drug of abuse (DOA) testing market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of drug abuse, growing demand for accurate and timely results, and rising awareness about the benefits of DOA testing. The urine segment is expected to dominate the global DOA testing market in terms of revenue share during the forecast period. This segment is anticipated to be driven by factors such as its low cost and easy availability. However, saliva-based tests are gaining popularity due their non-invasive nature and ability to detect recent drug use. In terms of application, hospitals are expected to account for the largest share of revenue in the global DOA testing market during 2018–2030 owingto th e increasing numberof patients seeking treatment for addiction disordersand growing adoptionofdrug screeningtestsby healthcare providers .
 Testing Industry Outlook.svg)
Product Definition:
Drug of Abuse (DOA) Testing is the process of testing a specimen, usually urine, for the presence of drugs that are not typically prescribed by a doctor. The purpose of Drug of Abuse (DOA) Testing is to detect drug use and help ensure safety in the workplace.
Urine:
Urine is a body fluid that is present in both men and women. Urine can be collected from the patient by means of a catheter or through an invasive procedure known as urological collection. The sample of urine is analyzed for its chemical composition to determine if it meets the legal requirements for drug testing.
Saliva:
Saliva is a body fluid that is produced in the gums of the teeth. It contains enzymes, proteins, and hormones. Saliva can contain drugs as well as bacteria from the mouth. The amount of drug or bacteria present in saliva depends on two factors such as frequency of use and oral habits (eating, drinking).
Drugs or chemicals get absorbed into the bloodstream through mucous membranes present in the mouth while using drugs orally.
Application Insights:
Based on the application, the market is segmented into hospitals, workplaces, at-home and others. Hospitals held the largest share of over 60% in 2017 owing to widespread usage of drugs by patients for committing suicide or for obtaining pleasure while using these substances. Moreover, hospitals are one of the major sources where DOA testing is conducted due to easy availability and low cost as compared to other settings such as laboratories or workplaces.
However, at-home testing has been observed to be on a rise since 2016 due to increasing awareness about drug use among individuals especially after watching movies/series depicting illegal drug use which has resulted in an increase in DOA testing kits sales at homes across countries worldwide including North America and Europe.
Regional Analysis:
Asia Pacific dominated the global market in 2017 and is expected to continue its dominance over the forecast period. The region has been witnessing an increasing number of substance abuse cases, which has led to a rise in demand for drug-related testing services. China, India, Japan, Australia and South Korea are some of the countries that have reported high incidences of drug abuse coupled with high unmet needs for DOA testing services.
The Asia Pacific market was followed by North America with a revenue share of around 25%. Factors such as local presence of key service providers offering advanced diagnostic solutions; well-established healthcare infrastructure; increased funding from government & other organizations; and growing awareness about early diagnosis are contributing towards regional growth. In addition, factors such as higher disposable income levels among individuals and families along with rising health concerns due to substance abuse is further anticipated to boost regional demand during the forecast period.
Growth Factors:
- Increasing incidence of drug abuse across the globe
- Growing demand for early diagnosis and treatment of drug abuse
- Rising public awareness about harmful effects of drug abuse
- Proliferation of rehabilitation centers for treatment of drug abusers
- Technological advancements in DOA testing methods
Scope Of The Report
Report Attributes
Report Details
Report Title
Drug of Abuse (DOA) Testing Market Research Report
By Type
Urine, Saliva, Hair, Others
By Application
Hospitals, Laboratories, Workplace, At-Home
By Companies
Siemens, Merck, Roche, Thermo Fisher Scientific, Bio-Rad, Abbott, Quest Diagnostics, Express Diagnostics Int'l, Psychemedics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Drug of Abuse (DOA) Testing Market Report Segments:
The global Drug of Abuse (DOA) Testing market is segmented on the basis of:
Types
Urine, Saliva, Hair, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Laboratories, Workplace, At-Home
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Siemens
- Merck
- Roche
- Thermo Fisher Scientific
- Bio-Rad
- Abbott
- Quest Diagnostics
- Express Diagnostics Int'l
- Psychemedics
 Testing Market Overview.svg)
Highlights of The Drug of Abuse (DOA) Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Urine
- Saliva
- Hair
- Others
- By Application:
- Hospitals
- Laboratories
- Workplace
- At-Home
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drug of Abuse (DOA) Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Testing Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Drug of abuse testing is a process used to identify substances that may be causing impairment in an individual. This can include drugs such as marijuana, cocaine, and opioids.
Some of the major companies in the drug of abuse (doa) testing market are Siemens, Merck, Roche, Thermo Fisher Scientific, Bio-Rad, Abbott, Quest Diagnostics, Express Diagnostics Int'l, Psychemedics.
The drug of abuse (doa) testing market is expected to grow at a compound annual growth rate of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Drug of Abuse (DOA) Testing Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Drug of Abuse (DOA) Testing Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Drug of Abuse (DOA) Testing Market - Supply Chain
4.5. Global Drug of Abuse (DOA) Testing Market Forecast
4.5.1. Drug of Abuse (DOA) Testing Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Drug of Abuse (DOA) Testing Market Size (000 Units) and Y-o-Y Growth
4.5.3. Drug of Abuse (DOA) Testing Market Absolute $ Opportunity
5. Global Drug of Abuse (DOA) Testing Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Drug of Abuse (DOA) Testing Market Size and Volume Forecast by Type
5.3.1. Urine
5.3.2. Saliva
5.3.3. Hair
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Drug of Abuse (DOA) Testing Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Drug of Abuse (DOA) Testing Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Laboratories
6.3.3. Workplace
6.3.4. At-Home
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Drug of Abuse (DOA) Testing Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Drug of Abuse (DOA) Testing Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Drug of Abuse (DOA) Testing Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Drug of Abuse (DOA) Testing Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Drug of Abuse (DOA) Testing Demand Share Forecast, 2019-2026
9. North America Drug of Abuse (DOA) Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Drug of Abuse (DOA) Testing Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Drug of Abuse (DOA) Testing Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Laboratories
9.4.3. Workplace
9.4.4. At-Home
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Drug of Abuse (DOA) Testing Market Size and Volume Forecast by Type
9.7.1. Urine
9.7.2. Saliva
9.7.3. Hair
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Drug of Abuse (DOA) Testing Demand Share Forecast, 2019-2026
10. Latin America Drug of Abuse (DOA) Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Drug of Abuse (DOA) Testing Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Drug of Abuse (DOA) Testing Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Laboratories
10.4.3. Workplace
10.4.4. At-Home
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Drug of Abuse (DOA) Testing Market Size and Volume Forecast by Type
10.7.1. Urine
10.7.2. Saliva
10.7.3. Hair
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Drug of Abuse (DOA) Testing Demand Share Forecast, 2019-2026
11. Europe Drug of Abuse (DOA) Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Drug of Abuse (DOA) Testing Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Drug of Abuse (DOA) Testing Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Laboratories
11.4.3. Workplace
11.4.4. At-Home
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Drug of Abuse (DOA) Testing Market Size and Volume Forecast by Type
11.7.1. Urine
11.7.2. Saliva
11.7.3. Hair
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Drug of Abuse (DOA) Testing Demand Share, 2019-2026
12. Asia Pacific Drug of Abuse (DOA) Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Drug of Abuse (DOA) Testing Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Drug of Abuse (DOA) Testing Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Laboratories
12.4.3. Workplace
12.4.4. At-Home
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Drug of Abuse (DOA) Testing Market Size and Volume Forecast by Type
12.7.1. Urine
12.7.2. Saliva
12.7.3. Hair
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Drug of Abuse (DOA) Testing Demand Share, 2019-2026
13. Middle East & Africa Drug of Abuse (DOA) Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Drug of Abuse (DOA) Testing Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Drug of Abuse (DOA) Testing Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Laboratories
13.4.3. Workplace
13.4.4. At-Home
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Drug of Abuse (DOA) Testing Market Size and Volume Forecast by Type
13.7.1. Urine
13.7.2. Saliva
13.7.3. Hair
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Drug of Abuse (DOA) Testing Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Drug of Abuse (DOA) Testing Market: Market Share Analysis
14.2. Drug of Abuse (DOA) Testing Distributors and Customers
14.3. Drug of Abuse (DOA) Testing Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Siemens
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Merck
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Roche
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Thermo Fisher Scientific
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Bio-Rad
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Abbott
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Quest Diagnostics
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Express Diagnostics Int'l
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Psychemedics
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
